Dr. Kol
Publications
Monitoring of controlled ovarian stimulation in IVF.
| Kol S, Castillo J, Trolice MP, Quaas AM. | J Assist Reprod Genet. 2024,41:1715–1717. | |
In Vitro fertilization (IVF) treatments in Maccabi Healthcare Services 2015-2020.
| Orvieto N, Segal Y, Kol S. | Harefuah, March 2024 (Hebrew). | |
Ideal frozen embryo transfer regime.
| Castillo J, Kol S. | Curr Opin Obstet Gynecol. 2024, 1;36:148-154. | |
LH supplementation in IVF: human nature, politics, and elephants in the room.
| Castillo J, Quaas AM, Kol S. | J Assist Reprod Genet. 2024;41:609-612. | |
Time-sensitive assessment of luteal phase progesterone after hCG ovulation triggering: Another brick off the wall?
| J. Castillo, S. Kol. | Reproductive Biomedicine Online , 2023, Nov;47(5):103324 | |
Luteinizing Hormone and Ovarian Stimulation for In-Vitro Fertilization: Do Science and Business Always Agree? | S. Kol P. Humaidan. | Science Repository, published: August 22, 2022. | |
Time, time time: see what governs the luteal phase endocrinology.
| S. Kol. | Gynecological Endocrinology. 2021;37:775-777. | |
The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients.
| P. Humaidan, B. Alsbjerg, H.O. Elbaek, B.B. Povlsen, R.J. Laursen, M.B. Jensen, A.T. Mikkelsen L.H. Thomsen, S. Kol, T. Haahr. | Reprod Biomed Online, 2021;42:1108-1118. | |
Reduced FSH and LH action: implications for medically assisted reproduction.
| E. Bosch, C. Alviggi, M. Lispi, A. Conforti, A.C. Hanyaloglu, D. Chuderland, M. Simoni, N. Raine-Fenning, P. Cre´ pieux, S. Kol, V. Rochira, T. D’Hooghe, and P. Humaidan. | Human Reproduction, 2021. 17;36:1469-1480. | |
Suboptimal response to GnRH agonist trigger: causes and practical management.
| Humaidan P, Kol S. | Curr Opin Obstet Gynecol. 2021 1;33:213-217 | |
IVF and the exogenous progesterone-free luteal phase.
| Kol S, Humaidan P. | Curr Opin Obstet Gynecol. 2021 1;33:188-195 | |
GnRH agonist triggering followed by 1500 IU of HCG 48 h after oocyte retrieval for luteal phase support.
| Kol S, Segal L. | Reproductive Biomedicine Online. 2020;41:854-858. | |
LH Supplementation in Ovarian Stimulation for IVF: The Individual, LH Deficient, Patient Perspective.
| Kol S. | Gynecol Obstet Invest. 2020;85:307-311. | |
The Importance of Mid-Follicular Phase Luteinizing Hormone Rise in GnRH Antagonist-Based Ovarian Stimulation for IVF.
| Vanetik S, Beck-Fruchter R, Segal L, Kol S. | Gynecol Obstet Invest. 2020;85:184-188. | |
Inadvertent use of depot GnRH agonist trigger and its effect on the luteal phase. A case report.
| Kol S, Fainaru O. | Reproductive Medicine International 2018;1:1-2. | |
Distinct and independent dielectrophoretic behaviour of the head and tail of sperm and its potential for the safe sorting and isolation of rare spermatozoa.
| Shuchat S, Park S, Kol S, Yossifon G. | Electrophoresis. 2019;40:1606-1614. | |
Ultra-Orthodox Jews and infertility diagnosis and treatment.
| Kol S. | Andrology. 2018;6:662-664. | |
A Rationale for Timing of Luteal Support Post Gonadotropin-Releasing Hormone Agonist Trigger.
| Kol S. | Gynecol Obstet Invest. 2019;84:1-5. | |
GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient? | Lawrenz B, Humaidan P, Kol S, Fatemi HM. | Reprod Biomed Online. 2018;36:75-77. | |
In vitro fertilization (ivf) treatment for viral diseases carriers: summary of treatment outcome of hiv-positive patients.
| Eshet S, Milner E, Segal L, Monzer A, Kol S. | Harefuah. 2017 Oct;156:670. | |
False positive blood hCG test following Corifollitropin alfa injection.
| Kol S, Gal M. | Hum Reprod. 2018 1;33:177. | |
Day two post retrieval 1500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger – a proof of concept study.
| Vanetik S, Segal L, Breizman T, Kol S. | Gynecol Endocrinol. 2018;34:132-135. | |
GnRH-agonist triggering for final oocyte maturation in GnRH-antagonist IVF cycles induces decreased LH pulse rate and amplitude in early luteal phase: a possible luteolysis mechanism.
| Tannus S, Burke Y, McCartney CR, Kol S. | Gynecol Endocrinol. 25:1-5, 2017. | |
GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus.
| Kol S, Fainaru O. | Rambam Maimonides Medical Journal 8:23, 2017. | |
Anovulatory Patients Demonstrate a Sharp Decline in LH Levels upon GnRH Antagonist Administration during IVF Cycles.
| Segal L, Fainaru O, Kol S. | Rambam Maimonides Medical Journal 8:21, 2017. | |
How Many Embryos Should Be Transferred? The Relevance of
Parity and Obstetric History.
| Fainaru O, Kol S. | Isr Med Assoc J. 18:364, 2016. | |
‘Model’ versus ‘everyday’ patients: can randomized controlled trial data really be applied to the clinic?.
| Hershkop E, Segal L, Fainaru O, Kol S. | Reprod Biomed Online. 34:274-279, 2017. | |
In Vitro fertilization (IVF) treatments in Maccabi Healthcare Services 2007-2014.
| Kol S, Bergovoy Yellin L, Segal Y and Porath A. | Israel Journal of Health Policy Research 5:14, 2016. DOI: 10.1186/s13584-016-0072-9. | |
Treatment strategies for the infertile polycystic ovary syndrome patient.
| Tannus S, Burke YZ, Kol S. | Womens Health (Lond Engl). 11:901-12, 2015. | |
GnRH agonist trigger does not always cause luteolysis: a case report. | Kol S, Breyzman T. | Reprod Biomed Online. 32:132-134, 2016. | |
‘Luteal coasting’ after GnRH agonist trigger – individualized, HCG-based, progesterone-free luteal support in ‘high responders’: a case series.
| Kol S, Breyzman T, Segal L, Humaidan P. | Reprod Biomed Online. 31:747-751, 2015. | |
Luteal phase support post IVF: individualized early stop. | Segal L, Breyzman T, Kol S. | Reproductive BioMedicine Online 31: 633–637, 2015. | |
The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors.
| Kol S, Humaidan P, Alsbjerg B, Engmann L, Benadiva C, García-Velasco JA, Fatemi H, Andersen CY. | Reproductive BioMedicine Online 30:563–565, 2015. | |
Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol. | Kol S. | Clinical Medicine Insights: Reproductive Health 8:59–64, 2014. | |
The use of portable CO2 incubator for cross-border shipping of embryos in an international egg donation program.
| Levron J, Zinchenko V, Kol S, Direnfeld M, Bider D. | Gynecol Endocrinol. 30:755-7, 2014. | |
Assisted reproductive technology in the presence of chronic viral disease.
| Kol S, Tannus S, Lightman A, Itskovitz J. | Harefuah 153:155-158, 2014. | |
Severe ovarian hyperstimulation after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze all” approach in GnRH antagonist protocol.
| Mousavi Fatemi H, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, García-Velasco JA. | Fertil Steril. 101:1008-11, 2014. | |
GnRH agonist triggering: recent developments.
| Kol S, Humaidan P. | Reproductive BioMedicine Online 26: 226– 230, 2013. | |
In-Vitro fertilization cycles and outcomes in Maccabi Healthcare Services in Israel 2007-2010.
| Sella T, Segal Y, Goren I, Chodick G, Shalev V, Homburg R, Bachar R, Kol S. | Harefuah 152:11-14, 2013. | |
The gonadotropin-releasing hormone antagonist protocol – the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.
| Kol S, Homburg R, Alsbjerg B, Humaidan P. | ACTA Obstetrica et Gynecologica Scandinavica 91:643-7, 2012. | |
Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte
maturation and intensive luteal support.
| Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov-Kochman R. | Hum. Reprod. 27:753-9, 2012. | |
Should Cochrane reviews be performed during the development of new concepts?
| P. Humaidan, Kol S, L. Engmann, C. Benadiva, E.G. Papanikolaou, and C. Yding Andersen, on behalf of the Copenhagen GnRH Agonist Triggering Workshop Group. | Hum. Reprod. 27:6-8, 2012. | |
New algorithm for OHSS prevention.
| E.G Papanikolaou, P.Humaidan, N. Polyzos, S Kalantaridou, Kol S, C. Benadiva, H.Tournaye, B. Tarlatzis. | Reproductive Biology and Endocrinology 2011, 9:14. | |
GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study.
| Kol S, Humaidan P, Itskovitz-Eldor J. | Hum. Reprod. 26:2874-77, 2011. | |
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
| Humaidan P, Kol S and Papanikolaou EG, on behalf of the ‘The Copenhagen GnRH Agonist Triggering Workshop Group’. | Human eproduction Update 2011 ;17:510-524. | |
Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome–a 20-year experience.
| Kol S, Itskovitz-Eldor J. | Semin reorod Med 28:500-505, 2010. | |
LH (as hCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango.
| Kol S, Humaidan P. | Reproductive BioMedicine Online 21:590-592, 2010. | |
Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation.
| Kol S, Dor J. | Reproductive BioMedicine Online 19:59-60, 2009. | |
Change, change, change: hormonal actions depend on changes in blood levels.
| Kol S, Homburg R. | Human Reproducion 23:1004-6, 2008. | |
GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
| Kol S, Solt I. | Journal of Assisted Reproduction and Genetics 25:63-66, 2008. | |
To add or not to add LH: consideration of LH concentration changes in individual patients.
| Kol S. | Reproductive BioMedicine Online 11:664-666, 2005. | |
Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further reseach.
| Kol S, Muchtar M. | Reproductive BioMedicine Online 10:575-577, 2005. | |
Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome.
| Kol S. | Fertil Steril 81:1-5, 2004. | |
Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent!
| Kol S. | Hum Reprod.18:1557-8. 2003. | |
Vascular endothelial growth factor – mediator of PHSS?
| Kol S. | Fertil Steril 79:1466, 2003. | |
Lower levels of inhibin A and pro- alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin.
| Nevo O, Eldar-Geva T, Kol S, Itskovitz-Eldor J. | Fertil Steril 79:1123-8, 2003. | |
Ovarian interleukin-1-induced gene expression: privileged
genes threshold theory. | Kol S, Kehat I, Adashi EY. | Med Hypotheses. 58:6-8, 2002. | |
Should we explore OHSS full clinical scope?…
| Kol S. | Hum Reprod. 16:595-6, 2001. | |
Severe OHSS: yes, there is a strategy to prevent it!
| Kol S, Itskovitz-Eldor J. | Hum Reprod. 15:2266-7, 2000. | |
Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication.
| Itskovitz-Eldor J, Kol S Mannaerts B. | Hum Reprod 15:1965-1968, 2000. | |
Ovarian stimulation in in vitro fertilization with or without the “long” gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome.
| Beloosesky R, Kol S, Lightman A, Itskovitz-Eldor J. | Fertil Steril 74:166-8, 2000. | |
The low responder female IVF patient with hypogonadotropic hypogonadism: do not give up!
| Lewit N, Kol S. | Fertil Steril 74:401-2, 2000. | |
GnRH antagonists in ART: lower embryo implantation?
| Kol S. | Hum Reprod; 5:1881-1882, 2000 Webtrack (12.6.2000). | |
Rat ovarian interleukin-1alpha: interleukin-1-dependent in vitro expression.
| Kol S, Wong KH, Ando M, Ben-Shlomo I, Adashi EY. | Endocrine 11:269-75, 1999. | |
Expression and hormonal regulation of rat ovarian interleukin-1beta converting enzyme, a putative apoptotic marker: endocrine- and aracrine-dependence.
| Irahara M, Ando M, Kol S, Adashi EY. | J Reprod Immunol 45:67-79, 1999. | |
Non-steroidal anti-inflammatory drugs (NSAIDs) block the late, prostanoid-dependent/ceramide-independent component of ovarian IL-1 action: implications for the ovulatory process.
| Ando M, Kol S, Irahara M, Sirois J, Adashi EY. | Mol Cell Endocrinol 157:21-30, 1999. | |
A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles.
| Lightman A, Kol S, Itskovitz-Eldor J. | Hum Reprod 14:2596-2599, 1999. | |
High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles .
| Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, and Itskovitz-Eldor J. | Hum Reprod 14:2242-2244, 1999. | |
Early transvaginal embryo aspiration: a safer method for selective reduction in high order multiple gestations.
| Coffler MS, Kol S, Drugan A, Itskovitz-Eldor J. | Hum Reprod 14:1875-1878, 1999. | |
The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1beta and of the type I and type II IL-1 receptors.
| Kol S, Ruutiainen-Altman K, Scherzer WJ, Ben-Shlomo I, Ando M, Rohan RM, Adashi EY. | Mol Cell Endocrinol 149:115-28, 1999. | |
Ovarian Interleukin-1 Receptor Antagonist in Rats: Gene Expression, Cellular Localization, Cyclic Variation, and Hormonal Regulation of a Potential Determinant of Interleukin-1 Action.
| Kol S, Donesky BW, Ruutiainen-Altman K, Ben-Shlomo I, Irahara M, Ando M, Rohan RM, Adashi EY. | Biol Reprod 61:274-282, 1999. | |
Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression
and activity.
| Kol S, Ben-Shlomo I, Ando M, Adashi EY. | Mol Hum Reprod 3:1095-9, 1997. | |
First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix
(Org 37462).
| Itskovitz-Eldor J, Kol S, Mannaerts B, Coelingh Bennink H. | Hum Reprod 13:294-5, 1998. | |
Rat ovarian prostaglandin endoperoxide synthase-1 and -2: periovulatory expression of granulosa cell-based interleukin-1-dependent enzymes.
| Ando M, Kol S, Kokia E, Ruutiainen-Altman K, Sirois J, Rohan RM, Payne DW, Adashi EY. | Endocrinology 139:2501-8, 1998. | |
Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression
and activity.
| Kol S, Ben-Shlomo I, Ando M, Adashi EY. | Mol Hum Reprod 1997, 3:1095-1099. | |
Transforming growth factor-beta1 is a potent inhibitor of interleukin-1beta action in whole ovarian dispersates.
| Derman SG, Kol S, Ben-Shlomo I, Resnick CE, Rohan RM, Adashi EY. | J Endocrinol 160:415-423, 1999. | |
Helium and oxygen treatment of severe air diving-induced neurologic decompression sickness.
| Shupak A, Melamed Y, Ramon Y, Bentur Y, Abramovich A, Kol S. | Arch Neurol 54:305-311, 1997. | |
Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
| Itskovitz-Eldor J, Kol S, Lewit N, Sealey JE. | J Clin Endocrinol Metab 82:461-464, 1997. | |
The incidence and possible relevance of Y-linked microdeletions in ICSI derived babies and their infertile fathers.
| Kent-First MG, Kol S, Muallem A, Manor D, Blazer S, First N, Itskovitz-Eldor J. | Mol Hum Reprod 2:943-950, 1996. | |
Assisted implantation: Direct intra-endometrial embryo transfer.
| Itskovitz-Eldor J, Filmar S, Manor D, Stein D, Lightman A, Kol S. | Gyncol Obstet Invest 43:73- 75, 1997. | |
Undocumented embryos: Do not trash them, FISH them.
| Manor D, Kol S, Lewit N, Lightman A, Stein D, Pillar M, Itskovitz-Eldor J. | Hum Reprod 11:2502-2506, 1996. | |
Thyroid function in early normal pregnancy: transient suppression of thyroid stimulating hormone, and stimulation of triiodothyronine.
| Kol S, Karnieli E, Kraiem Z, Itskovitz-Eldor J, Lightman A, Ish-Shalom S. | Gyncol Obstet Invest 42:227-229, 1996. | |
The presence of a sponsoring embryo in a batch of poor quality thawed embryos significantly increases pregnancy and implantation rate.
| Lightman A, Kol S, Wayner V, Vertman D, Manor D, Itskovitz-Eldor J. | Fertil Steril 67:711-6, 1997. | |
The Use of GnRH Analogues For the Induction of Preovulatory Gonadotropin Surge In Assisted Reproduction and Prevention of Ovarian Hyperstimulation Syndrome.
| Lewit N, Kol S, Manor D, Itskovitz-Eldor J. | Gynecol Endocrinol 9 (Suppl) 4:13-17, 1995. | |
Comparison of GnRH Analogs And Hcg For The Induction of Ovulation And Preventation of Ovarian Hyperstimulation Syndrome (OHSS): A Case-control Study.
| Lewit N, Kol S, Manor D, Itskovitz-Eldor J. | Hum Reprod 11:1399, 1996. | |
Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome? | Lewit N, Kol S, Itskovitz-Eldor J. | Fertil Steril 66:654, 1996. | |
Ovarian Hyperstimulation Syndrome after using Gonadotropin-releasing Hormone Agonist as a Trigger of Ovulation: Causes and implications.
| Kol S, Lewit N, Itskovitz-Eldor J. | Hum Reprod 11:1143, 1996. | |
The Rat Ovarian Phospholipase A2 System: Gene Expression, Cellular Localization, Activity Characterization, and Interleukin-1 Dependence.
| Kol S, Ruutiainen K, Ben-Shlomo I, Ando M, Payne DW, Adashi EY. | Endocrinology 1997;138:322- 331. | |
Interleukin-1b Stimulates Ovarian Phospholipase A2 (PLA2) Expression and Activity: Up-regulation of Both Secretory and Cystosolic PLA2.
| Kol S, Ben-Shlomo I, Ando M, Payne DW, Adashi EY. | Endocrinology 1997;138: 314-321. | |
Interleukin (IL)-1b Increases Glucose Uptake and Induces Glycolysis in aerobically Cultured Rat Ovarian Cells: Evidence that IL-1b may Mediate the Gonadotropin- Induced Midcyle Metabolic Shift. | Ben-Shlomo I, Kol S, Roeder LM, Resnick CE, Hurwitz A, Payne DW, Adashi EY. | Endocrinology 1997;138:2680-2688. | |
Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation.
| Kol S, Ben-Shlomo I, Payne DW, Ando M, Rohan RM, Adashi EY. | Mol Cell Endocrinol 137:117-25, 1998 | |
The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3.
| Kol S, Ben-Shlomo I, Ruutianen K, Ando M, Resnick CE, Rohan RM, Adashi EY. | J Clin Invest 1997, 99:2274-2283. | |
Detection and In Vitro Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-1 Receptor mRNA: Increased Expression During the Periovulatory Period.
| Scherzer WJ, Putowski LT, Kol S, Adashi EY, Rohan RM. | J Soc Gyn Invest 1996;3:131-9. | |
Ovarian expression, cellular localization, and hormonal regulation of rat secretory phospholipase A2: increased expression by interleukin-1 and by gonadotropins.
| Ben-Shlomo I, Kol S, Ando M, Altman KR, Putowski LT, Rohan RM, Adashi EY | Biol Reprod 1997;57:217-225. | |
Simplified riboprobe purification using starslucent straws as gel tubes.
| Kol S, Ben-Shlomo I, Adashi EY, Rohan RM. | Gen Alalysis 1996;12:129-132. | |
Interpretation of nonstress tests by an artificial neural network.
| Kol S, Thaler I, Paz N, Shmueli O. | Am J Obstet Gynecol 172:1372, 1995. | |
A novel nonhepatic hydroxycholosterol 7ahydroxylase that is markedly stimulated by interleukin-1b J
| Payne DW, Shackeleton C, Toms H, Ben-Shlomo I, Kol S, deMoura M, Strauss JF, Adashi EY. | Biol Chem 270:18888-96, 1995. | |
The potential role of oxygen in the prevention of neurologic deficit after cardiac surgery. | Kol S, Gordon CR, Melamed Y. | Intensive & Critical Care Digest 12:48, 1993. | |
Spinal Decompressionsickness in sport diving.
| Aharon-Peretz J, Adir Y, Gordon CR, Kol S. Gal N, Melamed Y. | Arch Neurol 50:753, 1993. | |
Use of GnRH-agonist to cause ovulation and prevent ovarian hyperstimulation sundrome.
| Itskovitz-Eldor J, Levron J, Kol S. | Clin Obstet Gynecol, 36:701, 1993. | |
Oxy-helium treatment of severe spinal decompression sickness after air diving. | Kol S, Adir Y, Gordon CR, Melamed Y. | Undersea Biomed Res 20:147, 1993. | |
The natural history of multiple pregnancies after assisted reproduction: Is spontaneous fetal reduction a clinically significant phenomenon?
| Kol S, Levron J, Lewit N, Drugan A, Itskovitz-Eldor J. | Fertil Steril 60:127, 1993. full text | |
Pulmonary barotrauma after a free dive – a possible
mechanism. | Kol S, Weisz G, Melamed Y. | Aviat Space Environ Med 64:236, 1993. | |
Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass.
| Kol S, Ammar R, Weisz G, Melamed Y. | Ann Thorac Surg, 55:401, 1993. | |
Massive air embolism – a possible cause of death after operative hysteroscopy using a 32% dextran 70 pump.
| Nachum Z, Kol S, Adir Y, Melamed Y. | Fertil Steril 58:836, 1992. | |
Carbon monoxide and coronary artery disease.
| Adir Y, Kol S, Melamed Y. | Harefuah, 122:249, 1992. | |
Peripartum changes in free and protein bound digoxin like immuno-reactive factor.
| Jakobi P, Kol S, Weissman A, Krivoy N. | J Reprod Med 37:127, 1992. | |
Effect of b-endorphin on human chorionic gonadotrophin secretion by placental explants.
| Barnea ER, Ashkenazy R, Tal Y, Kol S, Sarne Y. | Hum Reprod 6: 1327, 1991. | |
Hyperbaric oxygen treatment for carbon monoxide intoxication acquired in the sealed room during the Persian Gulf War.
| Adir Y, Bitterman H, Kol S, Melamed Y. | Israel Journal of Medical Sciences 27:669, 1991. | |
The intrauterine device, a transitional period.
| Kol S, Jakobi P, Paldi E. | Harefua 118:676, 1990. | |
Case report: preoperative diagnosis of fallopian tube carcinoma by
| Kol S, Gal D, Friedman M, Paldi E. | TVS and CA-125. Gynecologic Oncology 37:129, 1990. | |
Human embryonal extracts modulate placental function in the first trimester: effect of visceral tissues upon chorionic gonadotropin and progesterone secretion.
| Barnea ER, Simon RJ, Kol S. | Placenta 10:331, 1989. | |
The role of catecholamines in estradiol and progesterone secretion by cultured explants and cells of human term placenta.
| Barnea ER, Perlman R, Fakih H, Bick T, Kol S, Hochberg Z. | Acta Endocrinologica 121:767, 1989. | |
LH and FSH surges for final oocyte maturation: Is dual surge beneficial?. | Kol S. | in: Manual of ovulation induction & ovarian stimulation protocols, 3rd edition. Editors: Allahbadia and Merchant. Jaypee Brothers Medical Publishers, 2016, pp. 463-469. | |
Computer implementation of the new diabetes classification scheme. | Weiner F, Kanter Y, Kol S, Barzilai D. | Meth Inform Med 21:191, 1982. | |
Intravenous glucose tolerance test in gestational diabetes and pregnancy: manual vs. computerized assessment.
| Kanter Y, Kol S, Weiner F. | Eur J Obstet Gynecol Reprod Biol. 27:307, 1988. | |
Stimulatory effect of prolactin on human placental progesterone secretion at term in vitro: possible inhibitory effect on estradiol secretion.
| Barnea ER, Fares F, Kol S. | Placenta 10:37, 1989. | |
The Role of Growth Factors in Ovarian Function and Development.
| Evron A, Blumenfeld Z, Adashi E, Kol S | Glob. libr. women’s med., (ISSN: 1756-2228) 2015; DOI 10.3843/GLOWM.10288. | |
Assisted Reproductive Technology (ART), Reference Module in Biomedical Sciences.
| Kol S. | Elsevier. 17-Oct-2014 doi:10.1016/B978-0-12-801238-3.03880-0. | |
Reply: GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data.
| P. Humaidan, S. Kol, E.G. Papanikolaou, L. Engmann, C. Benadiva, J. Itskovitz-Eldor, E.J. Margalioth, E. Ricciarelli, D. Bodri, J.C. Castillo-Farfan, J.A. Garcia-Velasco, C. Yding Andersen, P. Devroey and B. Tarlatzis. | Hum. Reprod. Update 2012 18: 229-230. | |
Ovarian hyperstimulation prevention.
| Kol S. | The Global Library of Women’s Medicine.(2011) | |
A case of severe early-onset OHSS after GnRH-agonist triggering. | Kol S. | Letter to the Editor. Fertil Steril. 96:e151, 2011. | |
The role of growth factors in ovarian function and development.
| Kol S, Rohan RM and Adashi EY | The Global Library of Women’s Medicine. (2008) | |
Letter to the Editor: Reply: Investigating actions of changing hormone levels.
| R. Homburg, Kol S | Human Reproduction, doi:10.1093/humrep/den307. | |
The vanishing follicle in women aged over forty: Premature, mechanical, LH-independent luteinization may reflect oocyte-follicle low quality? | Kol S. | Med Hypotheses. 2008 Jan 10. | |
Ultrasound-guided embryo transfer – a special role in patients with certain uterine defects.
| Kol S. | Fertil Steril. 2008, 89(1):260. | |
GnRH agonist trigger: looking for the coin under the lamp post?
| Kol S. | Human Reproduction 21:1328, 2006. | |
Agonist trigger in the context of OHSS prevention: primum non nocere.
| Kol S. | Human Reproduction Update, advanced access published March 31, 2006. | |
Does ovulation triggering influence the risk of OHSS? In “Ovarian Hyperstimulation Syndrome. Chapter 20.
| Kol S. | Edited by Gerris, Olivennes, Delvingne, Taylor&Francis. 2006 | |
Luteal support post GnRH agonist trigger: do not stop too soon.
| Kol S. | Human Reproduction 20:3257, 2005. | |
Society’s contribution to assisted reproductive technology abuse.
| Kol S, Itskovitz-Eldor J. | Hum. Reprod. 20:2362, 2005. | |
Fertilization method is linked to gene defect. | Itskovitz-Eldor J. and Kol S. | Washington Post, February 20, 1997. | |
Oocyte donation: the shortage and a possible solution. | Kol S. | Medicine and Law 19:74-77, 1998. | |
Ovarian hyperstimulation syndrome: modern concepts in pathophysiology and management.
| Kol S, Lewit N, Itskovitz-Eldor J. | Mid East Fertil Soc J 1:246, 1996. | |
Medical examination of rape victims.
| Kol S. | Medicine and Law 15:59, 1996. | |
Infertility in intracytoplasmic-perm-injection-derived sons. | Kent-First MG, Kol S, Muallem A, Blazer S, Itskovitz-Eldor J. | Lancet 348:332, 1996. | |
Adjuvant hyperbaric oxygenation therapy in hand edema and ischemia. | Kol S, Adir Y, Shupak A, Stahl S. | Techniques in Hand and Upper Extremity Surgery 2:274-277, 1998. | |
Gas embolism in obstetrics and gynecology. | Weissman A, Kol S, Peretz BA. | J Reprod Med 41:103-111, 1996. | |
Assisted Reproductive Technology. | Kol S. | In: Encyclopedia of Endocrinology and Endocrine Diseases. Editor-in-Chief Luciano Martini, 2004, Academic Press, San Diego. California. | |
Hormonal Therapy of the Infertile Woman. | Kol S. | In: “Contemporary Endocrinology: Hormone Replacement Therapy”, second edition. Editor: Wayne Meikle, pp 525-536, 2003, Humana Press, Totowa, NJ. | |
Triggering ovulation with GnRH analogs. | Kol S, Itskovitz-Eldor J. | In: Serono Symposia. Ovulation: Evolving Scientific and Clinical Concepts. Eli Y. Adashi, Editor. Springer-Verlag, New York, Inc. 2000, pp. 308-316. | |
Disorders of the gonadotrophs. | Itskovitz-Eldor J, Kol S. | In: Reproductive Endocrinology, Surgery and Technology. Adashi EY, Rock JA, Rosenwaks Z Editors, Raven Press, NY (1996). | |
The role of growth factors in ovarian function and development. | Kol S, Rohan RM and Adashi EY | In: Sciarra JJ (Ed.), Gynecology and Obstetrics, Lippincott Williams and Wilkins, Philadelphia, PA. Vol. 5, 11:1-13. (2000) | |
Intra-ovarian factors regulating ovarian function. | Kol S, Adashi EY. | Current Opinions in Obstetrics and Gynecology, 7:209, 1995. | |
First surrogacy pregnancy and delivery | Kol S. | Israel, Maariv, 23.2.1998. |
Lectures
LH supplementation in IVF: It is all about endocrinology.
| Tartu. Estonia, 20.10.23. | |
Individualized LH supplementation in ovarian stimulation for IVF: Just a slogan or a reality.
| Athens, Greece, July, 2023. | |
Time to personalize luteal phase support – fresh and FET cycles.
| Cappadocia, Turkiye, May 2023. | |
LH supplementation and ART: For whom?
| Ho Chi Minh City, Vietnam, November, 2022. | |
To add LH or not to add LH during ovarian stimulation | Buenos Aires Argentina, March 2022. | |
hCG as trigger: The good the bad and the alternative. | Ferring Excahnges in Fertility (Scientific Committee), September 29-30, 2022, Copenhagen, Denmark. | |
Individualized LPS: Fresh and FET cycles. | Turkish Society of Reproductive Medicine (TSRM): Evidence based approach in ART. September 17, 2022, Ankara, Turkiye. | |
Progesterone-free luteal support for IVF. | 17th Annual conference of Indian Fertility Society, FERTIVISION 2021, 10th-12th December, 2021. | |
Poor prognosis patients and LH: from RCT’s and metanalyses to personalized medicine. | 9th International IVIRMA Congress, Spain, Virtual Congress Week, November 15-19, 2021. | |
To add LH or not to add LH? Is this a personal question? | 25th Brazilian Congress on Assisted Reproduction and 15th Red Latinoamericana de Reproducción Assistida, November 5, 2021. | |
LH supplementation in ovarian stimulation for IVF: The individual, LH deficient, patient perspective. | VITA NOVA 2021 Meeting, Bratislava, Slovakia, 21.10.2021. | |
Severe LH and FSH deficiency in an infertile patient undergoing ART.
| Merck Mini-Symposium, Chateau du Lac, Genval, Belgium 4.10.2021. | |
Progesterone free luteal support in IVF.
| IVF Worldwide online congress, October 1-3, 2021. | |
LH and FSH deficiency: personalization of controlled ovarian stimulation treatment. | Potruguese Fertility Society Annual meeting, Merck symposium. September 24, 2021. | |
A wider spectrum in FSH and LH deficiency.
| The «6th Congress of the Hellenic Society of Fertility & Sterility». Thessaloniki, Greece, May 28-30, 2021, Satellite Symposium 1: Connecting the details for life. | |
Radio Kol Chai interview October 15, 2020 (Hebrew)
| link | |
The endocrinology of the luteal phase in IVF cycles (Hebrew)
| IVF Worldwide Webinar Series, April 6, 2020. | |
Natural pregnancy in advanced age (Hebrew).
| Tel Aviv University, February 21, 2020. | |
I-study: Continued medical education, Fertility: Ovulation triggering methods, and luteal phase support, second part. | ||
I-study: Continued medical education, Fertility: Ovulation triggering methods, and luteal phase support, first part. | ||
Triggering for ovulation – What are the options (hCG, GnRH a, Dual Triggering)? | EXCEMED, Improving success in ART, Tallinn, Estonia, 19 October 2019. (plenary). | |
What kind and dose of gonadotropins to use? Are biosimilars an option? | EXCEMED, Improving success in ART, Tallinn, Estonia, 19 October 2019. (plenary). | |
Working together with the Jewish Fertility Foundation.
| ||
Endometrial receptivity can be improved with luteal support fine-tuning. 1st
| World Congress on Women’s Health Innovations and Inventions (WHII): Addressing Unmet Needs. July 9-11, 2019 Tel Aviv, Israel. | Video clip, IVF Elisha, in Hebrew. link |
Treatment strategies in infertile PCOS.
| The World Association of Perinatal Medicine, Novel approaches in Fertility and Ovulation, Dead Sea, Jordan, May 25th, 2019 (plenary). | |
Prevention of OHSS: Modern Technique.
| The World Association of Perinatal Medicine, Novel approaches in Fertility and Ovulation, Dead Sea, Jordan, May 25th, 2019 (plenary). | |
The roadmap to LH supplementation in IVF.
| Sociedade Portuguesa de Medicina da Reprodução. Porto, Portugal, May 10, 2019 (plenary). | |
The luteal phase: a new era.
| Israel Fertility Society meeting, January 2019. | |
The endocrinology of the luteal in IVF. | Tel Aviv University, An Update in Fertility Treatments Symposium, June 15th, 2018. | |
A novel look at luteal phase support post IVF.
| XII International Congress on Reproductive Medicine, Moscow, Russia, 16-19.1.2018. | |
Reducing implantation failure: novel approach to luteal phase support.
| Merck organised European Fertility Meeting (PERSONALISING THE PATIENT Journey in ART to SHORTEN TIME TO LIVE BIRTH) November 24th-25th, 2017 at Sheraton Congress Hotel, Frankfurt, Germany. | |
LH supplementation in antagonist protocol
| November 17th, 2017. | |
Radio interview: “The experts”, Haifa Radio, June 6th, 2017
| ||
IVF treatment of high responders.
| Israel Fertility Association, School of Reproductive Endocrinology, April, 2016. | |
TV interview: IVF results in Israel, March 9th, 2016.
| ||
Quality measurement in IVF
| Maccabi Health Care, March 2016. | |
Regulatory guidelines for IVF: HBV and HCV infected individuals. | The ABC for fertility treatments in carriers of hepatitis B&C. Special conference of AYALA, The Israel Fertility Association endorced by the IsASL, The Israel Association for the study of the liver, January 2016, Tel Aviv, (Hebrew). | |
IVF results in Maccabi Health Services 2011-2014.
| Research Day, Maccabi-Assuta, Tel Aviv, January 2016 (Hebrew). | |
Management of fertility treatment in PCOS patients.
| Update in Ob/Gyn, Leumit Sick Fund, Dead Sea, Israel, October 9, 2015. | |
Luteal coasting post GnRH agonist trigger.
| COGI 2015, Frankfurt, Germany, May 14-16, 2015. | |
Treatment strategies for the infertile PCO patient.
| COGI 2014, Ho Chi Minh City, Vietnam, November 20-22, 2014. | |
IVF in Israel, quality vs. quantity.
| Carmel Hospital, Haifa, Israel, October 2014. | |
Recombinant LH, recombinant hCG and GnRH agonist to trigger ovulation in antagonist cycles: a critical Evaluation.
| WOOSP 2014, Jaipur India, August 6-10, 2014. | |
Luteal support post agonist trigger for OHSS prevention: The introduction of “luteal coasting” as a novel approach.
| WOOSP 2014, Jaipur India, August 6-10, 2014. | |
Elonva in poor responders. | WOOSP 2014, Jaipur India, August 6-10, 2014. | |
GnRH agonist and individualized luteal phase hCG support will avoid OHSS in PCOS. Toward friendly stimulation in Assisted Reproductive Technology.
| Hillel Yafe, Hadera Israel, March 2014. | |
IVF 2020, Maccabi Health Care, February 2014.
| ||
OHSS prevention: Yes, we can!
| 11th Internatinal Symposium on GnRH, February 9-11, 2014, Salzburg, Austria. | |
Individualized treatment from theory to practice: the private case of adding LH during GnRH antagonist based stimulation protocol.
| 11th Internatinal Symposium on GnRH, February 9-11, 2014, Salzburg, Austria. | |
GnRH-a to trigger ovulation should be used in all PCOS patients to prevent OHSS.
| COGI conference, Singapore, July 2012. | |
Prevention of OHSS.
| Updates in Infertility Treatment, Budapest, Hungary, 8-10 February, 2012. | |
OHSS: Should this be treated or prevented?
| Asia Pacific COGI conference, Bangkok, Thailand, November 2011. | |
Does GnRHa triggering completely abolish OHSS? GnRH agonist for triggering of final oocyte maturation – time for a paradigm shift.
| ESHRE Campus, Madrid, Spain, 3 December 2010. | |
Advanced age fertility: Can we improve the results?
| The 10th Annual Meeting of the Israeli Society for Community Gynecology, Israel, October 17, 2007. | |
Prevention of OHSS. | Serono Symposia, St. Petersburg, Russia, May 5-6, 2006. | |
GnRH agonist instead of hCG to trigger ovulation in GnRH antagonist cycles.
| ESHRE Campus, Brussels, December 10th, 2004. |